Matches in Wikidata for { <http://www.wikidata.org/entity/Q91856331> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q91856331 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91856331 description "scientific article published on 21 February 2019" @default.
- Q91856331 description "wetenschappelijk artikel" @default.
- Q91856331 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91856331 description "գիտական հոդված հրատարակված 2019 թվականի փետրվարի 21-ին" @default.
- Q91856331 name "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 name "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 type Item @default.
- Q91856331 label "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 label "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 prefLabel "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 prefLabel "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 P1104 Q91856331-CD440066-6E6F-4600-BA45-CF99CEFCF406 @default.
- Q91856331 P1433 Q91856331-AC766401-7361-4AAD-A06F-8FA437273059 @default.
- Q91856331 P1476 Q91856331-D809AE9F-DB3F-4F8E-9B6A-2107E5F606B1 @default.
- Q91856331 P2093 Q91856331-0B4B1617-95E9-4987-AAC1-18C5DA219F3A @default.
- Q91856331 P2093 Q91856331-AD78DD63-6ED3-42E2-B758-D484D67BC8A2 @default.
- Q91856331 P2093 Q91856331-C055E520-0E03-4461-B6DF-1FB8D98397DE @default.
- Q91856331 P304 Q91856331-ACA55EB3-7FF0-48B2-AF41-7617FE44E9C4 @default.
- Q91856331 P31 Q91856331-4802F48A-62A0-4638-9A39-1A9F73C49CBD @default.
- Q91856331 P356 Q91856331-FB8D64C4-A496-44B2-B7C9-AC37BC42B3DD @default.
- Q91856331 P478 Q91856331-8FFB979B-40A8-4632-9858-1EEBF065A6D1 @default.
- Q91856331 P577 Q91856331-17593C0F-6D51-4EBB-B464-B3F9D4F6031B @default.
- Q91856331 P698 Q91856331-2CFA3416-F547-483D-9FEF-C4931A10E631 @default.
- Q91856331 P921 Q91856331-0DC46F2B-9C4E-4CFD-9210-10BCDB050F7B @default.
- Q91856331 P921 Q91856331-634CE94B-C4AD-47CD-B00D-49586B8CDCE7 @default.
- Q91856331 P356 J.LFS.2019.02.043 @default.
- Q91856331 P698 30797819 @default.
- Q91856331 P1104 "+7" @default.
- Q91856331 P1433 Q5256275 @default.
- Q91856331 P1476 "Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells" @default.
- Q91856331 P2093 "Changhwan Yeo" @default.
- Q91856331 P2093 "Eun-Ok Lee" @default.
- Q91856331 P2093 "Hyo-Jeong Lee" @default.
- Q91856331 P304 "267-273" @default.
- Q91856331 P31 Q13442814 @default.
- Q91856331 P356 "10.1016/J.LFS.2019.02.043" @default.
- Q91856331 P478 "221" @default.
- Q91856331 P577 "2019-02-21T00:00:00Z" @default.
- Q91856331 P698 "30797819" @default.
- Q91856331 P921 Q1424593 @default.
- Q91856331 P921 Q181257 @default.